Scientist II, Translational Research and Clinical Biomarkers

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company headquartered in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.) dedicated to addressing patient needs in oncology, urology, women’s health, rare diseases, cell & gene therapies, and CNS. With multiple marketed products and a diverse pipeline of early‑ to late‑stage investigative assets, the company seeks to accelerate discovery, research, and development to bring novel therapies to patients sooner.

Scientist II – Translational Research & Medicine‑Oncology. The role focuses on advancing translational research to support oncology programs in clinical trial stages, designing, overseeing, and interpreting studies on mechanisms of action, resistance pathways, and new indications, and supporting biomarker analysis.

• Develop hypotheses by integrating insights from scientific literature, preclinical and clinical data.
• Design experiments to support identification of mechanism of action, resistance mechanisms, and potential indications.
• Manage translational research and biomarker studies conducted with CROs and academic investigators to ensure high‑quality, timely delivery of data.
• Maintain organized, detailed logs of studies and data to ensure accuracy, reproducibility, and compliance with regulatory standards.
• Present data and insights in internal meetings and cross‑functional program team discussions.

• Scientific curiosity with ability to generate and test hypotheses that inform drug development.
• Excellent problem‑solving and critical‑thinking skills to interpret complex data.
• Strong organizational skills and attention to detail in managing studies, data, and documentation.
• Strong project management and vendor oversight skills.
• Adaptability and resilience in a fast‑paced, evolving research environment.

• PhD degree in a related field of science (Biology, Biochemistry, Molecular & Cellular biology, Cancer Biology, Immunology).
• 1‑3 years of postdoctoral or industry research experience.
• Familiarity with oncology research preferred.
• Experience in DNA damage response (DDR) biology or related pathways is highly preferred.

Base salary range: $ – $. Compensation may include merit‑based increases, short‑term incentive plan participation, 401(k) eligibility, medical, dental, vision, life and disability insurance, and time‑off benefits in line with applicable state laws.

Sumitomo Pharma America (SMPA) is an Equal Employment Opportunity (EEO) employer. Qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, age, ancestry, nationality, marital status, domestic partnership or civil union status, sex, gender, sexual orientation, disability, veteran or military status, domestic violence victim status, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other characteristic protected by law.